California Enters Insulin Manufacturing: Can We Expect to See a California Effect?
Bill of Health
JUNE 26, 2023
Once approved by the FDA, CalRx insulin will be made available at $30 to all Californians who need it. Increased access to drug pricing data can inform innovation policy decisions on exclusivities, competition, and access for the pharmaceutical industry in general. Insulin is the first product the initiative will manufacture.
Let's personalize your content